LENZ
NASDAQ · Pharmaceuticals
Lenz Therapeutics Inc
$3.01
-0.45 (-13.01%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+364.5% upside
Low Target
$9.74
Average Target
$13.98
High Target
$16.17
Current Price
$3.01
Current
$3.01
$3.01
Target
$13.98
$13.98
$9.74
$13.98 avg
$16.17
Scenario Analysis
Bear Case
$9.74
223.6%
Low target
Base Case
$13.98
+364.5%
Avg target
Bull Case
$16.17
+437.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$32.13
-90.6% from high
52-Week Low
$2.80
+7.5% from low
Target vs 52W High
$13.98
-56.5% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.93
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals